
Alberto Martini, MD, discusses cretostimogene grenadenorepvec in urothelial carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Alberto Martini, MD, is an assistant professor of urology and the director of research in the department of urology at the University of Cincinnati

Alberto Martini, MD, discusses cretostimogene grenadenorepvec in urothelial carcinoma.

Alberto Martini, MD, discusses the current optimal role of nadofaragene firadenovec in the BCG-unresponsive NMIBC treatment paradigm.

Alberto Martini, MD, discusses the evolving role of intravesical therapies in patients with high-risk non–muscle-invasive bladder cancer.